Current research on respiratory viral infections: Fourth International Symposium.
作者信息
Ison Michael G, Mills John, Openshaw Peter, Zambon Maria, Osterhaus Albert, Hayden Frederick
机构信息
University of Virginia School of Medicine, Charlottesville, VA, USA.
出版信息
Antiviral Res. 2002 Aug;55(2):227-78. doi: 10.1016/s0166-3542(02)00055-4.
Abstract
摘要
相似文献
1
Current research on respiratory viral infections: Fourth International Symposium.
Antiviral Res. 2002 Aug;55(2):227-78. doi: 10.1016/s0166-3542(02)00055-4.
2
Current research on respiratory viral infections: Fifth International Symposium.
Antiviral Res. 2004 Jun;62(3):75-110. doi: 10.1016/j.antiviral.2003.12.006.
3
Current research on respiratory viral infections: Third International Symposium.
Antiviral Res. 2001 Jun;50(3):157-96. doi: 10.1016/s0166-3542(01)00136-x.
4
VII International Symposium on Respiratory Viral Infections.
Antivir Ther. 2007;12(4 Pt B):671-93.
5
Current research on respiratory viral infections: XIIth International Symposium.
Antivir Ther. 2012;17(1 Pt B):227-53. doi: 10.3851/IMP2066. Epub 2012 Feb 3.
6
18th International Conference on Antiviral Research. Respiratory viruses.
IDrugs. 2005 Jun;8(6):465-6.
7
Respiratory viral infections. Preface.
Semin Respir Crit Care Med. 2011 Aug;32(4):371-2. doi: 10.1055/s-0031-1283277. Epub 2011 Aug 19.
8
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.
Antiviral Res. 1999 Jul;42(3):149-75. doi: 10.1016/s0166-3542(99)00034-0.
9
Reducing the impact of viral respiratory infections in children.
Pediatr Clin North Am. 2005 Jun;52(3):695-710, v. doi: 10.1016/j.pcl.2005.02.010.
10
Anti-viral agents: potential utility in exacerbations of asthma.
Curr Opin Pharmacol. 2013 Jun;13(3):331-6. doi: 10.1016/j.coph.2013.04.010. Epub 2013 May 9.
引用本文的文献
1
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist-Synthesis, Characterization, and In Vivo Activity.
J Funct Biomater. 2025 Jan 19;16(1):34. doi: 10.3390/jfb16010034.
2
Fluorine-Functionalized Polyphosphazene Immunoadjuvant: Synthesis, Solution Behavior and In Vivo Potency.
Molecules. 2023 May 21;28(10):4218. doi: 10.3390/molecules28104218.
3
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge.
J Funct Biomater. 2022 Dec 27;14(1):16. doi: 10.3390/jfb14010016.
4
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.
Nanomedicine. 2021 Apr;33:102359. doi: 10.1016/j.nano.2021.102359. Epub 2021 Jan 18.
5
Polyphosphazene immunoadjuvants: Historical perspective and recent advances.
J Control Release. 2021 Jan 10;329:299-315. doi: 10.1016/j.jconrel.2020.12.001. Epub 2020 Dec 5.
6
and Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.
Mol Pharm. 2021 Feb 1;18(2):726-734. doi: 10.1021/acs.molpharmaceut.0c00487. Epub 2020 Jun 23.
7
Disseminated adenovirus infection causing severe ARDS.
BMJ Case Rep. 2017 Jan 17;2017:bcr2016217524. doi: 10.1136/bcr-2016-217524.
8
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.
Clin Exp Vaccine Res. 2015 Jan;4(1):23-45. doi: 10.7774/cevr.2015.4.1.23. Epub 2015 Jan 30.
9
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.
Pediatr Infect Dis J. 2011 Apr;30(4):284-8. doi: 10.1097/INF.0b013e3181ff863b.
10
A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits.
Vaccine. 2010 Jun 17;28(28):4445-51. doi: 10.1016/j.vaccine.2010.03.062. Epub 2010 Apr 13.
本文引用的文献
1
The serial cultivation of human diploid cell strains.
Exp Cell Res. 1961 Dec;25:585-621. doi: 10.1016/0014-4827(61)90192-6.
2
A cytopathogenic agent isolated from naval recruits with mild respiratory illnesses.
Proc Soc Exp Biol Med. 1957 Feb;94(2):262-7. doi: 10.3181/00379727-94-22915.
3
On the isolation of influenza virus from mid-ear discharge of influenza otitis media.
Jpn J Med Sci Biol. 1955 Oct;8(4-5):373-7. doi: 10.7883/yoken1952.8.373.
4
Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice.
Mol Psychiatry. 2002;7(6):633-40. doi: 10.1038/sj.mp.4001046.
5
Combined antiviral-antimediator treatment for the common cold.
J Infect Dis. 2002 Jul 15;186(2):147-54. doi: 10.1086/341455. Epub 2002 Jul 3.
6
A defective type 1 response to rhinovirus in atopic asthma.
Thorax. 2002 Apr;57(4):328-32. doi: 10.1136/thorax.57.4.328.
7
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.
Lancet. 2002 Mar 9;359(9309):831-4. doi: 10.1016/S0140-6736(02)07953-9.
8
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects.
J Infect Dis. 2002 Feb 15;185(4):540-4. doi: 10.1086/338570. Epub 2002 Jan 31.
9
Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness.
Curr Opin Neurobiol. 2002 Feb;12(1):115-8. doi: 10.1016/s0959-4388(02)00299-4.
10
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma.
Eur Respir J. 2002 Jan;19(1):68-75. doi: 10.1183/09031936.02.00226302.
Zotero 插件